Literature DB >> 15143801

Identifying the binding mode of a molecular scaffold.

Doron Chema1, Doron Eren, Avner Yayon, Amiram Goldblum, Andrea Zaliani.   

Abstract

We describe a method for docking of a scaffold-based series and present its advantages over docking of individual ligands, for determining the binding mode of a molecular scaffold in a binding site. The method has been applied to eight different scaffolds of protein kinase inhibitors (PKI). A single analog of each of these eight scaffolds was previously crystallized with different protein kinases. We have used FlexX to dock a set of molecules that share the same scaffold, rather than docking a single molecule. The main mode of binding is determined by the mode of binding of the largest cluster among the docked molecules that share a scaffold. Clustering is based on our 'nearest single neighbor' method [J. Chem. Inf. Comput. Sci., 43 (2003) 208-217]. Additional criteria are applied in those cases in which more than one significant binding mode is found. Using the proposed method, most of the crystallographic binding modes of these scaffolds were reconstructed. Alternative modes, that have not been detected yet by experiments, could also be identified. The method was applied to predict the binding mode of an additional molecular scaffold that was not yet reported and the predicted binding mode has been found to be very similar to experimental results for a closely related scaffold. We suggest that this approach be used as a virtual screening tool for scaffold-based design processes.

Mesh:

Substances:

Year:  2004        PMID: 15143801     DOI: 10.1023/b:jcam.0000022561.76694.5b

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  46 in total

1.  ConsDock: A new program for the consensus analysis of protein-ligand interactions.

Authors:  Nicodème Paul; Didier Rognan
Journal:  Proteins       Date:  2002-06-01

2.  Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

Authors:  M Mohammadi; G McMahon; L Sun; C Tang; P Hirth; B K Yeh; S R Hubbard; J Schlessinger
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

3.  The "nearest single neighbor" method-finding families of conformations within a sample.

Authors:  Doron Chema; Amiram Goldblum
Journal:  J Chem Inf Comput Sci       Date:  2003 Jan-Feb

4.  Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors.

Authors:  S Trumpp-Kallmeyer; J R Rubin; C Humblet; J M Hamby; H D Showalter
Journal:  J Med Chem       Date:  1998-05-21       Impact factor: 7.446

5.  Structure-based design of inhibitors of the rice blast fungal enzyme trihydroxynaphthalene reductase.

Authors:  D B Jordan; G S Basarab; D I Liao; W M Johnson; K N Winzenberg; D A Winkler
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

6.  Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases.

Authors:  L Sun; N Tran; C Liang; S Hubbard; F Tang; K Lipson; R Schreck; Y Zhou; G McMahon; C Tang
Journal:  J Med Chem       Date:  2000-07-13       Impact factor: 7.446

7.  Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.

Authors:  J M Hamby; C J Connolly; M C Schroeder; R T Winters; H D Showalter; R L Panek; T C Major; B Olsewski; M J Ryan; T Dahring; G H Lu; J Keiser; A Amar; C Shen; A J Kraker; V Slintak; J M Nelson; D W Fry; L Bradford; H Hallak; A M Doherty
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

8.  Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines.

Authors:  P Traxler; G Bold; J Frei; M Lang; N Lydon; H Mett; E Buchdunger; T Meyer; M Mueller; P Furet
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

9.  Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.

Authors:  Jeremy Kua; Yingkai Zhang; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

10.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more
  3 in total

1.  Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands.

Authors:  Lars Richter; Chris de Graaf; Werner Sieghart; Zdravko Varagic; Martina Mörzinger; Iwan J P de Esch; Gerhard F Ecker; Margot Ernst
Journal:  Nat Chem Biol       Date:  2012-03-25       Impact factor: 15.040

2.  Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein.

Authors:  Freya Klepsch; Peter Chiba; Gerhard F Ecker
Journal:  PLoS Comput Biol       Date:  2011-05-12       Impact factor: 4.475

Review 3.  Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.

Authors:  Valère Lounnas; Tina Ritschel; Jan Kelder; Ross McGuire; Robert P Bywater; Nicolas Foloppe
Journal:  Comput Struct Biotechnol J       Date:  2013-04-02       Impact factor: 7.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.